For the details of Johnson & Johnson Innovation - JJDC, Inc.'s stock buys and sells, go to https://www.gurufocus.com/guru/johnson+%26+johnson+innovation+-+jjdc%2C+inc./current-portfolio/portfolio
These are the top 5 holdings of Johnson & Johnson Innovation - JJDC, Inc.- Fate Therapeutics Inc (FATE) - 3,379,064 shares, 40.11% of the total portfolio.
- Arrowhead Pharmaceuticals Inc (ARWR) - 3,260,869 shares, 32.66% of the total portfolio.
- Protagonist Therapeutics Inc (PTGX) - 2,449,183 shares, 6.44% of the total portfolio.
- Legend Biotech Corp (LEGN) - 1,629,173 shares, 5.99% of the total portfolio.
- MeiraGTx Holdings PLC (MGTX) - 2,898,550 shares, 5.73% of the total portfolio.
Johnson & Johnson Innovation - JJDC, Inc. initiated holding in Pulmonx Corp. The purchase prices were between $41.35 and $69.02, with an estimated average price of $49.13. The stock is now traded at around $60.010000. The impact to a portfolio due to this purchase was 0.05%. The holding were 5,639 shares as of 2020-12-31.
Sold Out: Provention Bio Inc (PRVB)Johnson & Johnson Innovation - JJDC, Inc. sold out a holding in Provention Bio Inc. The sale prices were between $11.79 and $18.94, with an estimated average price of $15.01.
Sold Out: Genocea Biosciences Inc (GNCA)Johnson & Johnson Innovation - JJDC, Inc. sold out a holding in Genocea Biosciences Inc. The sale prices were between $1.91 and $2.67, with an estimated average price of $2.28.
Here is the complete portfolio of Johnson & Johnson Innovation - JJDC, Inc.. Also check out:
1. Johnson & Johnson Innovation - JJDC, Inc.'s Undervalued Stocks
2. Johnson & Johnson Innovation - JJDC, Inc.'s Top Growth Companies, and
3. Johnson & Johnson Innovation - JJDC, Inc.'s High Yield stocks
4. Stocks that Johnson & Johnson Innovation - JJDC, Inc. keeps buying
